Baseline Characteristics Module

Baseline Characteristics Module

The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.

Baseline Characteristics Module path is as follows:

Study -> Results Section -> Baseline Characteristics Module

Baseline Characteristics Module


Ignite Creation Date: 2025-12-26 @ 10:36 AM
Ignite Modification Date: 2025-12-26 @ 10:36 AM
NCT ID: NCT02949128
Population Description: Full Analysis Set (FAS): all participants who received at least 1 dose of ravulizumab, had at least 1 post-baseline efficacy assessment, and met pre-specified eligibility criteria.
Study: NCT02949128
Study Brief:
Results Section: NCT02949128